Noxopharm Health Care
Biotech Cancer Healthcare

$0.043 0.002 (4.88%)

High $0.05	Low $0.04	Trades 61	Turnover $61,445	Volume 1,415,719
30 June 2023 at 4:10pm

If you were already registered, log in here.

Market Cap (13-Nov) $11,693,202 (896th)	Close (30-Jun) $0.043 0 (0%)	Volume (30-Jun) 1,415,719	Shortsold (25-Aug) 4,188 (0.00%) (598th)
52w High $0.110	52w Low $0.032	P/E -	EPS -0.02

Short Interest

ASIC data, 25 Aug 2026

% Shorted

0.00% 0.00

vs 0.00% prior report

Most Shorted Rank

598th

of 711 shorted ASX stocks

Peak Short

2.88%

Sep 2016

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	NOX NOX Ann: Noxopharm Corporate Presentation
	1 (current) 2 3
	NOX NOX Ann: Veyonda Abstract Published at ASCO Annual Meeting 2022
	NOX NOX Ann: March 2022 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: Orphan Drug Designation Granted to Noxopharm by US FDA
	NOX NOX Ann: First Patient Treated in CEP-2 Sarcoma Trial
	NOX NOX Ann: Appendix 4D and Half Year 2022 Financial Report
	NOX NOX Ann: Initial Director's Interest Notice - GM
	NOX NOX Ann: December 2021 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: Noxopharm Presents at H.C. Wainwright BioConnect Conference
	NOX NOX Ann: Noxopharm Receives A$5.865M R & D Tax Rebate
	NOX NOX Ann: Noxopharm Announces Leadership Transition
	NOX NOX Ann: Noxopharm DARRT-2 Cancer Trial Update
	NOX NOX Ann: Notification of cessation of securities - NOX
	NOX NOX Ann: Change of Director's Interest Notice - GK
	NOX NOX Ann: Noxopharm Annual General Meeting Results
	NOX NOX Ann: Licencing Deal Expands Noxopharm Drug Opportunities
	NOX NOX Ann: Noxopharm 2021 AGM Corporate Presentation
	NOX NOX Ann: Noxopharm 2021 AGM Chairmans Address
	NOX NOX Ann: Retraction of Grant Announcement
	NOX NOX Ann: Trading Halt
	NOX NOX Ann: Noxopharm Awarded A$8.8M Aust Govt Grant for Sarcoma Trial
	NOX NOX Ann: DARRT-2 Trial Commences in the U.S.
	NOX NOX Ann: Unlisted Options Expiring on 30 November 2021
	NOX NOX Ann: Veyonda and Opdivo IONIC Study First Patient Dosed
	NOX NOX Ann: Patent Granted for Veyonda and Low Dose Chemotherapy
	NOX NOX Ann: Jobkeeper s323DB Notice
	NOX NOX Ann: 2021 AGM Notice of Meeting and Proxy
	NOX NOX Ann: 2021 AGM Letter to Shareholders and Proxy
	NOX NOX Ann: September 2021 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Application for quotation of securities - NOX
	NOX NOX Ann: Veyonda Achieves Important U.S. Patent Claims
	NOX NOX Ann: Noxopharm 2021 Annual Report
	NOX NOX Ann: Noxopharm Updated Corporate Presentation
	NOX NOX Ann: Change of Registered Office and Principal Place of Business
	NOX NOX Ann: Appendix 4E and Audited Financial Statements
	NOX NOX Ann: Appendix 4G and Corporate Governance Statement
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Application for quotation of securities - NOX
	NOX NOX Ann: Pre-clinical Data Supports a Role for Veyonda in COVID-19
	NOX NOX Ann: NOXCOVID Program to Expand After Positive Phase 1 Results
	NOX NOX Ann: Trading Halt
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Application for quotation of securities - NOX
	NOX NOX Ann: Additional Information on US NCI Collaboration
	NOX NOX Ann: NOX and US Govt Peak Cancer Agency Announce Collaboration
	NOX NOX Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
	NOX NOX Ann: June 2021 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: DARRT-2 Study Receives IND Approval from FDA
	NOX NOX Ann: Noxopharm Secures Key European Patent Allowance for Veyonda

If you were already registered, log in here.

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

Upcoming Floats (8)

MATRIX CRITICAL MINERALS LIMITED

MTX

SUPER MINERALS LTD

S88

MAVERICK URANIUM LIMITED

MAV

Fitgenes

ATW $7.5m raise

RIO DE ORO CORP LTD

RDO $30m raise

Adbri Ltd

ABC $5m raise

RAMSAY GENERALE DE SANTE SA

RGS

Gratifii

MBM

Top

End of Day Prices

Date	Close	Volume	Change
13-Nov	$0.04	875,672	+0.00 (5.71%)
12-Nov	$0.04	5,165	0.00 (2.78%)
11-Nov	$0.04	891,748	0.00 (2.70%)
10-Nov	$0.04	177,897	+0.00 (5.71%)
09-Nov	$0.04	13,500	0.00 (0.00%)
06-Nov	$0.04	546,819	0.00 (0.00%)
05-Nov	$0.04	1,518,548	0.00 (2.78%)
04-Nov	$0.04	942,642	-0.01 (25.00%)
02-Nov	$0.05	36,023	0.00 (2.04%)
30-Oct	$0.05	0	0.00 (0.00%)
29-Oct	$0.05	0	0.00 (0.00%)
28-Oct	$0.05	0	0.00 (0.00%)
27-Oct	$0.05	0	0.00 (0.00%)
26-Oct	$0.05	5,540	-0.01 (10.91%)
23-Oct	$0.06	0	0.00 (0.00%)
2 up, 6 down, and 7 flat days

Noxopharm Health Care
Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Noxopharm Health Care Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Noxopharm Health Care
Biotech Cancer Healthcare